8.00 0.08(1.07%)09/16/2024
Biocryst Pharmaceuticals Inc. (BCRX)
Biocryst Pharmaceuticals Inc. (BCRX)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
Headline | Time (ET) | Source |
---|---|---|
BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium | 09/06 02:00 | globenewswire.com |
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 09/04 07:00 | globenewswire.com |
BioCryst to Present at Upcoming Investor Conferences | 08/22 07:00 | globenewswire.com |
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2024 Earnings Call Transcript | 08/05 11:44 | seekingalpha.com |
Can BioCryst (BCRX) Climb 99.43% to Reach the Level Wall Street Analysts Expect? | 08/05 11:01 | zacks.com |
BioCryst Pharmaceuticals (BCRX) Reports Q2 Loss, Tops Revenue Estimates | 08/05 09:11 | zacks.com |
BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update | 08/05 07:00 | globenewswire.com |
7 Small-Cap Stocks to Buy for Large-Scale Gains | 07/30 12:25 | investorplace.com |
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know | 07/29 11:06 | zacks.com |